Ibsrela Alternatives Compared
| Ibsrela (tenapanor) | Linzess (linaclotide) | Zelnorm (tegaserod) |
|
|---|
| Ibsrela (tenapanor) | Linzess (linaclotide) | Zelnorm (tegaserod) |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Irritable Bowel Syndrome with Constipation. Ibsrela may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Chronic Idiopathic Constipation, Irritable Bowel Syndrome with Constipation, Functional Constipation, Irritable Bowel Syndrome. Linzess may also be used for purposes not listed in this... View more |
Prescription only
Prescribed for Irritable Bowel Syndrome with Constipation. Zelnorm may also be used for purposes not listed in this medication guide. |
Related suggestions Irritable Bowel Syndrome with Constipation
|
|||||||||||||||
| More about Ibsrela (tenapanor) | More about Linzess (linaclotide) | More about Zelnorm | ||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||
|
Ibsrela has an average rating of 9.5 out of 10 from a total of 7 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
Linzess has an average rating of 6.7 out of 10 from a total of 886 ratings on Drugs.com. 56% of reviewers reported a positive effect, while 26% reported a negative effect. |
Zelnorm has an average rating of 8.8 out of 10 from a total of 42 ratings on Drugs.com. 87% of reviewers reported a positive effect, while 11% reported a negative effect. |
||||||||||||||||
| Drug Class | ||||||||||||||||||
| Side Effects | ||||||||||||||||||
| Generic Availability | ||||||||||||||||||
|
N/A |
||||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||
View all Ibsrela prices |
View all Linzess prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||||||||||
| Dosage Forms Available | ||||||||||||||||||
|
|
|
||||||||||||||||
| Brand Names | ||||||||||||||||||
| Other tenapanor brands include: Xphozah |
N/A |
N/A |
||||||||||||||||
| Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||
|
N/A |
N/A |
16 hours |
||||||||||||||||
| CSA Schedule ** View glossary of terms | ||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | ||||||||||||||||||
|
Summary unavailable. See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | ||||||||||||||||||
|
No known drug interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
A total of 59 drugs are known to interact with Linzess:
|
A total of 2 drugs are known to interact with Zelnorm:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
|
||||||||||||||||
| Disease Interactions | ||||||||||||||||||
| First Approval Date | ||||||||||||||||||
|
September 12, 2019 |
August 30, 2012 |
July 24, 2002 |
||||||||||||||||
| WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||
| More Information | ||||||||||||||||||
| Patient resources | ||||||||||||||||||
| Professional Resources | ||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.